At the Oncology Department of the Small Animal Clinic, University of Ljubljana, we are collaborating with the Finnish biotech company DeepScan Diagnostics to develop a new generation of diagnostic tests for early cancer detection and treatment monitoring in dogs. Our research focuses on circulating free DNA (cfDNA), a biomarker that can be isolated from a dog’s blood plasma.